Precipio Inc. Common Stock (PRPO)

About PRPO

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clini…

Sector

Industrials

Industry

Biotechnology: Laboratory Analytical Instruments

Employees

61

Website

www.precipiodx.com/

Fundamentals

1-day range

$28.6$30.5

Market cap

$39.55M

P/E (trailing)

—

P/E (forward)

73.97

EPS (trailing)

$-0.51

Dividend yield

—

Beta

1.35

Avg. volume

86.6K

Dividend pay date

April 29, 2019

Precipio Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• PRPO

  Precipio Inc. Common Stock

  $28.85

  ▼ 1.50%
  Market cap $39.55MP/E —
  $14.28$33.63
• CIRC

  Circle8 Group Inc. Common Stock

  $0.7246

  ▲ 2.34%
  Market cap $60.19MP/E —
  $0.4773$0.98
• BNGO

  Bionano Genomics Inc. Common Stock

  $1.19

  ▼ 1.65%
  Market cap $12.79MP/E —
  $1$5.5
• RPID

  Rapid Micro Biosystems Inc. Class A Common Stock

  $1.56

  ▼ 3.11%
  Market cap $97.88MP/E —
  $1.52$4.94
• NAUT

  Nautilus Biotechnology Inc. Common Stock

  $0.8828

  ▼ 2.35%
  Market cap $128.53MP/E —
  $0.62$4.31
• LAB

  Standard BioTools Inc. Common Stock

  $0.64

  ▼ 1.54%
  Market cap $339.09MP/E 3.47
  $0.6251$1.72
• PACB

  Pacific Biosciences of California Inc. Common Stock

  $1.4

  ▼ 10.00%
  Market cap $441.05MP/E —
  $1.07$2.73

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/17/2026
• Precipio Q2 EPS $(0.12) Down From $0.05 YoY, Sales $7.021M Up From $5.654M YoY
  benzinga · 8/14/2026
• Precipio Q2 EPS $(0.12) Down From $0.05 YoY, Sales $7.021M Up From $5.654M YoY
  Benzinga · 8/14/2026
• Precipio Announces Q2-2026 Shareholder Update Call
  Yahoo · 7/31/2026

• Christina Rizopoulos Valauri · July 15, 2026 · Grant

  108 @ $25.24
• Jeffrey Cossman · July 15, 2026 · Grant

  416 @ $25.24
• David Seth Cohen · July 15, 2026 · Grant

  520 @ $25.24
• Richard A. Sandberg · May 21, 2026 · Sale

  900 @ $25.02
• Richard A. Sandberg · May 20, 2026 · Sale

  2.0K @ $24.89
• Richard A. Sandberg · May 20, 2026 · Sale

  500 @ $25
• Richard A. Sandberg · May 19, 2026 · Sale

  600 @ $24.42
• Christina Rizopoulos Valauri · April 15, 2026 · Grant

  93 @ $29.49
• Jeffrey Cossman · April 15, 2026 · Grant

  365 @ $29.49
• David Seth Cohen · April 15, 2026 · Grant

  445 @ $29.49
• Ahmed Zaki Sabet · April 1, 2026 · Buy

  19 @ $27.93

Institutional Ownership

March 31, 2026

Total shares held

142.3K

Total value held

$3.61M

Institutional holders

14